A detailed history of Cwm, LLC transactions in Kempharm, Inc stock. As of the latest transaction made, Cwm, LLC holds 468 shares of KMPH stock, worth $2,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares
468
Previous 431 8.58%
Holding current value
$2,311
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
N/A
37 Added 8.58%
468 $3,000
Q2 2024

Jul 09, 2024

BUY
N/A
17 Added 4.11%
431 $2,000
Q1 2024

Apr 05, 2024

BUY
N/A
254 Added 158.75%
414 $2,000
Q1 2022

Apr 21, 2022

SELL
$5.0 - $9.26 $1,250 - $2,315
-250 Reduced 60.98%
160 $1,000
Q4 2020

Sep 15, 2021

BUY
$8.0 - $18.72 $3,280 - $7,675
410 New
410 $5,000
Q4 2020

Jan 27, 2021

SELL
$8.0 - $18.72 $3,280 - $7,675
-410 Closed
0 $0
Q3 2020

Sep 15, 2021

BUY
$4.05 - $14.24 $1,660 - $5,838
410 New
410 $5,000
Q3 2020

Oct 19, 2020

SELL
$4.05 - $14.24 $1,660 - $5,838
-410 Closed
0 $0
Q2 2020

Sep 15, 2021

BUY
$2.75 - $5.06 $1,127 - $2,074
410 New
410 $5,000
Q2 2020

Jul 22, 2020

SELL
$2.75 - $5.06 $1,127 - $2,074
-410 Closed
0 $0
Q1 2020

Sep 15, 2021

BUY
$2.96 - $11.92 $1,213 - $4,887
410 New
410 $5,000
Q1 2020

Apr 28, 2020

SELL
$2.96 - $11.92 $1,213 - $4,887
-410 Closed
0 $0
Q4 2019

Sep 14, 2021

BUY
$4.5 - $11.36 $1,845 - $4,657
410 New
410 $5,000
Q4 2019

Jan 27, 2020

SELL
$4.5 - $11.36 $1,845 - $4,657
-410 Closed
0 $0
Q3 2019

Sep 14, 2021

BUY
$10.83 - $27.04 $4,440 - $11,086
410 New
410 $5,000
Q3 2019

Oct 22, 2019

SELL
$10.83 - $27.04 $4,440 - $11,086
-410 Closed
0 $0
Q2 2019

Sep 14, 2021

BUY
$19.2 - $29.76 $7,872 - $12,201
410 New
410 $5,000
Q2 2019

Jul 31, 2019

SELL
$19.2 - $29.76 $7,872 - $12,201
-410 Closed
0 $0
Q1 2019

Sep 02, 2021

BUY
$26.4 - $44.8 $10,824 - $18,368
410 New
410 $0

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.